Table of Content



1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary
3.1. Snippet by Products and Services
3.2. Snippet by Assay Type
3.3. Snippet by Technology
3.4. Snippet by Indication
3.5. Snippet by End User
3.6. Snippet by Region

4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Increasing developments in immune-oncology sector
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. Lack of Expertise
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis

5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Products and Services
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
7.1.2. Market Attractiveness Index, By Products and Services
7.2. Instruments*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Consumables
7.4. Software and Services

8. By Assay Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
8.1.2. Market Attractiveness Index, By Assay Type
8.2. Cell proliferation assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cell migration and invasion assays
8.4. Phagocytosis assays
8.5. Immune cell killing assays
8.6. Others

9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. PCR*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. NGS
9.4. ISH
9.5. Immunoassay
9.6. Flow cytometry
9.7. Others

10. By Indication
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Colorectal cancer*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Breast Cancer
10.4. Lung Cancer
10.5. Melanoma
10.6. Others

11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Academic Institutes*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Organizations
11.4. Diagnostics centers
11.5. Others

12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles
14.1. Merck KGaA
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Thermo Fisher Scientific Inc.
14.3. Crown Bioscience
14.4. Lunaphore Technologies SA.
14.5. Eve Technologies.
14.6. Vivia Biotech S.L
14.7. Illumina, Inc.
14.8. Bio-Rad Laboratories, Inc
14.9. Charles River Laboratories
14.10. PerkinElmer Inc.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us